Perspectives in immunotherapy of lung cancer.
D000818:Animals; D000951:Antigens, Neoplasm / Q000032:analysis; D001500:BCG Vaccine / Q000627:therapeutic use; D002283:Carcinoma, Bronchogenic / Q000276:immunology; D002294:Carcinoma, Squamous Cell / Q000276:immunology; D064987:Cell- and Tissue-Based Therapy; D006801:Humans; D007111:Immunity, Cellular; D007116:Immunization, Passive; D007153:Immunologic Deficiency Syndromes / Q000276:immunology; D007167:Immunotherapy / Q000379:methods*; D008175:Lung Neoplasms / Q000276:immunology*; D008213:Lymphocyte Activation; D009362:Neoplasm Metastasis; D009369:Neoplasms / Q000276:immunology; D009374:Neoplasms, Experimental / Q000276:immunology; D011379:Prognosis; D011425:Propionibacterium acnes / Q000276:immunology
D000951:Antigens, Neoplasm; D001500:BCG Vaccine